A 2026 medical review lists the most common appendix cancer treatment mistakes, and most of them are avoidable. Knowing them can help you ask better questions and push for stronger care.
I read the full paper. It was written for surgeons, not for patients. I want to walk you through it in plain words, because the choices it describes can change how a person is treated, and sometimes whether treatment is offered at all.
Why this review matters for appendix cancer patients
Appendix cancer is a peritoneal malignancy. That means it grows in the lining of the belly, called the peritoneum. The review covers all of these belly cancers, including ovarian and colon cancers that spread to the lining, so not every point is about appendix cancer alone. Appendix cancer is also not a single disease. Goblet cell, signet ring, neuroendocrine, and low-grade mucinous types can each need a different plan. I pulled out the appendix cancer treatment mistakes below that I think matter most for the Appendicure community, which spans more than 1,400 members across 44 countries.
The appendix cancer treatment mistakes the review warns about
The paper lists ten mistakes. I kept the order and put each one in plain words.
1. Treating it as hopeless
Some doctors still treat any appendix cancer that has spread as a dead end. That is often wrong, and it is wrong across the subtypes. Cancer moving into the lining of the belly does not mean nothing can be done. Low-grade mucinous tumors, often called LAMN, and PMP are the clearest example. For many people with these, a surgery that removes the disease, sometimes paired with heated chemo washed through the belly (called CRS and HIPEC), can offer long-term disease control, and in some cases even a cure. Higher-grade tumors, goblet cell, and other appendiceal types can also be treated with real intent, not just comfort care, and what is possible depends on the details of your case. The exact type under the microscope drives the plan, so do not accept “nothing can be done” without an expert second opinion.
2. Missing or delaying the diagnosis
Belly pain, bloating, and fluid buildup get blamed on other things, like IBS or an old surgery. One trap is testing the belly fluid and trusting a negative result. That test can miss mucinous appendix tumors, so a negative result does not rule cancer out. Ask about a CT scan, a needle biopsy, or a look inside with a small scope.
3. Using the wrong imaging
A basic CT can undercount how much disease is there. The review says to ask for a dedicated peritoneal-protocol CT with IV and oral contrast. For some non-mucinous tumors, a diffusion-weighted MRI (a special MRI setting) can actually show more than a CT. PET scans have a place too. They are good at spotting disease outside the belly, but they often miss mucinous appendix tumors, so they are not the test to lean on for that. The right scan depends on your tumor type, so this is worth a direct conversation with your team.
4. Skipping real staging
Before a major operation, the team should measure how much disease is present. Surgeons use a score called the PCI for this. Many also look inside first with a small scope, called staging laparoscopy. This step is what separates a planned surgery from a nasty surprise on the table.
5. Going to a low-volume center
CRS and HIPEC is one of the largest operations in cancer surgery. Centers that do a lot of them tend to have fewer complications and better results. It is fair, and smart, to ask a surgeon how many of these they do each year. If your hospital rarely treats appendix cancer, asking for a second opinion isn’t being difficult. It’s exactly what this review recommends.
6. Letting one doctor decide alone
Big calls should not rest on a single opinion. A team that includes a surgeon, a medical oncologist, a radiologist, and a pathologist should review the case together. This is often called a tumor board, or an MDT. Ask whether your case has been through one.
7. Starting chemo when surgery should come first
Many appendiceal tumors do not respond well to chemo, particularly low-grade ones. Starting chemo first in a case that could be operated on can waste time and let the disease grow. For low-grade appendiceal tumors, surgery first is often the better path. Some higher-grade or goblet cell tumors are treated with chemo, so this is not a blanket rule. Your grade and type change everything here, so it stays a team decision.
8. Accepting a partial surgery
The goal of the operation is to remove all disease that can be seen. A surgery that leaves large amounts behind can carry the full risk without the full benefit. The message is simple. Complete removal, or do not start.
9. Overusing the heated chemo
HIPEC, the heated chemo bath, is not automatic and is not right for every case. It should follow the evidence and your specific situation, not get added as a just-in-case step. In the wrong setting it can do more harm than good.
10. Dropping follow-up
After treatment, a clear surveillance plan matters. That means scans and tumor-marker blood tests on a set schedule. If the disease returns in the belly only, it can sometimes be treated again, which is why steady follow-up is worth the effort.
A note on standards
The care guide I point families to is the 2025 consensus guideline for appendiceal tumors, not the older colon cancer playbook. This review lines up with that modern approach. It treats appendix cancer as its own set of diseases that deserve their own plan.

What you can do
You can’t control everything, but you can make sure the right questions get asked. These five are a good place to start.
- Is my case being reviewed by a full team, not one doctor alone?
- How many of these surgeries does this center do each year?
- Can all the visible disease be removed?
- What imaging and staging happen before any surgery?
- What is my follow-up plan after treatment?
Common questions
What are the most common appendix cancer treatment mistakes?
The 2026 review points to treating the disease as hopeless, delaying the diagnosis, using the wrong imaging, skipping proper staging, going to a low-volume center, letting one doctor decide alone, starting chemo before surgery, accepting a partial surgery, overusing heated chemo, and dropping follow-up.
Does a negative belly-fluid test mean I do not have appendix cancer?
No. Fluid tests can miss mucinous appendix tumors, so a clear result does not rule cancer out. Ask about imaging, a biopsy, or a small scope.
Why does the hospital I choose matter for CRS and HIPEC?
It is one of the most complex operations in cancer surgery. Centers that do many of them tend to have fewer complications and better results.
Is chemo always the first step for appendix cancer?
No. Many appendiceal tumors resist chemo, and surgery is often first, especially for low-grade tumors. Your plan depends on your type and grade, so it should be a team decision.
Join the Patient-Led Global Appendix Cancer Registry
The registry collects molecular, genomic, and pathology data to help researchers understand appendix cancer and speed better treatment. It takes a few minutes. Pick the link for where you live.
Join the Registry: United States Join the Registry: InternationalRead more
Gallbladder removal during CRS/HIPEC: what a new study means
Appendix cancer imaging: two advances worth watching
Why a colonoscopy usually misses appendix cancer
Understanding these appendix cancer treatment mistakes will not make anyone a doctor. It can make you a sharper advocate for yourself or someone you love. If this kind of work matters to you, you can help keep it going by supporting Appendicure here.

Leave a Reply